Pinned post
Delighted to announce results of our ph 2 RCT for Rx of GA. 24 pts recruited so far. BCVA gains of 15.3 ltrs in 4 pts at M18 in Ph 1 and 13.8 in 12 pts at M6 across ph 1 and 2. US IND in early 2027 ! m.economictimes.com/small-biz/entr…
@EyestemResearch
Pinned post
Delighted to announce results of our ph 2 RCT for Rx of GA. 24 pts recruited so far. BCVA gains of 15.3 ltrs in 4 pts at M18 in Ph 1 and 13.8 in 12 pts at M6 across ph 1 and 2. US IND in early 2027 ! m.economictimes.com/small-biz/entr…View quoted post on X
Bharat Innovates 2026 proudly presents Eyestem, a pioneering Indian biotech startup transforming the future of regenerative medicine and vision restoration through advanced stem cell therapy. Based in Bengaluru, Eyestem is developing scalable and affordable cell replacement therapies for incurable retinal diseases such as Dry Age Related Macular Degeneration (AMD). Its flagship innovation, Eyecyte-RPE™, uses induced pluripotent stem cell (iPSC) technology to regenerate damaged retinal cells and potentially restore vision for millions worldwide.View quoted post on X
As part of Bharat Innovates 2026, Eyestem will showcase its breakthrough healthcare innovations at the Final Showcase in Nice, France from 14–16 June 2026. With ongoing clinical trials, global investor backing, and a mission to democratize access to advanced therapies, Eyestem represents the next generation of Indian deep-tech innovation in healthcare and biotechnology.
The startup is not only advancing medical science but also bringing hope to patients battling incurable blindness across the globe.
@narendramodi @PMOIndia @eduminofindia @dpradhanbjp @PrinSciAdvGoI @Vineet_K26 @sanjayjavin @IndiaDST @AICTE_INDIA @ugcindia @pibindia @DDNewslive @airnewsalerts @sjaishankaroffc @Chatty111Prasad @MEABharat @IndiainPortugal @IndiaembFrance @CGIMarseille @eoiberlin @IndiainIreland @HCI_London @iitbombay @SINEIITB @paniitindia @EyestemResearch
#BharatInnovates2026 #Eyestem #Biotech #StemCellTherapy #HealthTech
Within just 6 months of the launch of Rs 1 lakh crore “Research, Development and Innovation” #RDI Fund Scheme by PM Sh @narendramodi, ₹50 crore was electronically disbursed under the scheme, reflecting the Government’s commitment to accelerate private sector participation in India’s R&D journey.View quoted post on X
The First Agreement Signing with ETEs and the First Fund Release under the #RDIScheme, hosted by @tdbgoi, mark a significant step towards strengthening India’s innovation and deep-tech ecosystem.
Delighted to report approval from CDSCO to start ph 2 clinical trial of Eyecyte-RPE for treatment of Geographic Atrophy. With a stable surgical technique and good efficacy/safety data from ph one (14.8 ltrs at 6 M/14.6 ltrs at 12 M/No SAEs), we remain cautiously optimistic!View quoted post on X